Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Latent Tuberculosis and NAT2[original query] |
---|
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. European journal of clinical pharmacology 2006 Jun 62 (6): 423-9. Vuilleumier Nicolas, Rossier Michel F, Chiappe Alberto, Degoumois Florence, Dayer Pierre, Mermillod Bernadette, Nicod Laurent, Desmeules Jules, Hochstrasser Den |
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators. Pharmacogenetics and genomics 2020 11 31 (3): 68-73. Yoo Hyounggyoon, Chun Ji Sang, Cho Joo-Youn, Kim Sang-Heon, Yoon Jihoon G, Goo Lee Min, Yu Kyung-Sang, Jang In-Jin, Oh Jaeseo |
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. International journal of environmental research and public health 2019 Dec 17 (1): . Yu Ya-Yen, Tsao Shih-Ming, Yang Wen-Ta, Huang Wei-Chang, Lin Ching-Hsiung, Chen Wei-Wen, Yang Shun-Fa, Chiou Hui-Ling, Huang Yi-W |
- Page last reviewed:Feb 1, 2024
- Content source: